Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-27

Clinical Trial Update: The Impact of Olive Oil Polyphenol Supplementation on Metabolic Syndrome Parameters: Preclinical Investigations Have Demonstrated That Olive Oil Polyphenols, Notably Oleocanthal, Oleacein, and Allied Secoiridoids, Possess Anti-inflammatory and Antioxidant Attributes [NA]

View source ↗

Summary

Completed clinical trial evaluating olive oil polyphenol supplementation for metabolic syndrome parameters; preclinical data suggest anti-inflammatory and antio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olive oil polyphenol supplement (oleocanthal, oleacein) (oleocanthal; oleacein; secoiridoids)

Snippet

Sponsor: Apostolos Loukas Medical Centre Cyprus | Conditions: Metabolic Syndrome | NA | Status: COMPLETED